AI Analysis AI Analysis of IUGNF
AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment
Trading Strategy
PDF

Volatile ride for Imugene Limited stock price on Monday moving between $0.180 and $0.200
(Updated on Nov 17, 2025)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Nov 06, 2025 Loss -11.11%

The Imugene Limited stock price fell by -9.75% on the last day (Monday, 17th Nov 2025) from $0.222 to $0.200. During the last trading day the stock fluctuated 11.17% from a day low at $0.180 to a day high of $0.200. The price has fallen in 6 of the last 10 days and is down by -13.19% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -4 thousand shares and in total, 7 thousand shares were bought and sold for approximately $1.33 thousand.

Given the current short-term trend, the stock is expected to rise 22.50% during the next 3 months and, with a 90% probability hold a price between $0.245 and $0.401 at the end of this 3-month period.

IUGNF Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Imugene Limited stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.213 and $0.235. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, October 14, 2025, and so far it has fallen -34.38%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Imugene Limited stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.180 and $0.176. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Imugene Limited finds support just below today's level at $0.180. If this is broken, then the next support from accumulated volume will be at $0.176 and $0.174.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0201 between high and low, or 11.17%. For the last week the stock has had daily average volatility of 8.25%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (IUGNF) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Imugene Limited to open at $0.193, and during the day (based on 14 day Average True Range), to move between $0.190 and $0.210, which gives a possible trading interval of +/-$0.0207 (+/-10.91%) up or down from last closing price. If Imugene Limited takes out the full calculated possible swing range there will be an estimated 10.91% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.202 (0.85%) than the support at $0.180 (10.00%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Imugene Limited stock A Buy?

The Imugene Limited stock holds several negative signals and despite the positive trend, we believe Imugene Limited will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.885 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $0.193 ( 3.35%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk

IUGNF Performance

Trading levels for IUGNF

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.213 6.70%
R2 0.206 2.86%
R1 0.201 0.489%
Price 0.200
S1 0.186 -7.19%
S2 0.181 -9.56%
S3 0.173 -13.40%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.226 13.18%
R2 0.222 10.80%
R1 0.202 0.85%
Price 0.200
S1 0.180 -10.00%
S2 0.176 -12.00%
S3 0.174 -13.00%

FAQ

What is the symbol for Imugene Limited Stock and on which exchange is it traded?
The symbol for Imugene Limited is IUGNF and it is traded on the PINK (Pink Sheets).

Should I buy or sell Imugene Limited Stock?
The Imugene Limited stock holds several negative signals and despite the positive trend, we believe Imugene Limited will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Imugene Limited Stock?
Imugene Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Imugene Limited Stock.

What's the current price of Imugene Limited Stock?
As of the end of day on the Nov 17, 2025, the price of an Imugene Limited (IUGNF) share was $0.200.

What is the 52-week high and low for Imugene Limited Stock?
The 52-week high for Imugene Limited Stock is $0.342 and the 52-week low is $0.0044.

What is the market capitalization of Imugene Limited Stock?
As of the Nov 17, 2025, the market capitalization of Imugene Limited is 57.725M.

When is the next earnings date for Imugene Limited?
The upcoming earnings date for Imugene Limited is Feb 26, 2026.
Click to get the best stock tips daily for free!
ABOUT IMUGENE LIMITED
Imugene
Imugene Limited, a clinical stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumors in Australia. Its lead product is HER-Vaxx, a HER2-positive cancer vaccine that stimulates a polyclonal antibody response against HER2/neu receptors in gastric and breast cancer. The company's HER-Vaxx is in Phase 1b/2 study for gastric cancer. It also engages in developing P...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE